Publication | Open Access
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
85
Citations
23
References
2021
Year
Dupilumab in addition to methylprednisolone and azathioprine seems superior to methylprednisolone/azathioprine alone in controlling disease progression and accelerating the tapering of glucocorticoids.
| Year | Citations | |
|---|---|---|
Page 1
Page 1